Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene.

Literature DB >> 1847475

Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene.

J L Cantello¹, A S Anderson, A Francesconi, R W Morgan.

Abstract

We have isolated a stable, recombinant Marek's disease virus (MDV) containing the lacZ gene of Escherichia coli inserted into the unique short region of the genome. The nucleotide sequence of the insertion site indicates that it lies within a sequence homologous to the US2 gene of herpes simplex virus. Stable insertion of the lacZ gene into the MDV US2 gene indicates that the site is nonessential for MDV growth in cell culture.

Entities: Gene Species

Mesh：

Substances：
beta-Galactosidase

Year: 1991 PMID： 1847475 PMCID： PMC239942

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

19 in total

1. Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Authors: R R Spaete; E S Mocarski
Journal: Proc Natl Acad Sci U S A Date: 1987-10 Impact factor: 11.205

2. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.

Authors: D J Goldstein; S K Weller
Journal: J Virol Date: 1988-01 Impact factor: 5.103

3. Field trials with the herpes virus of turkeys (HVT) strain FC126 as a vaccine against Marek's disease.

Authors: H G Purchase; W Okazaki; B R Burmester
Journal: Poult Sci Date: 1971-05 Impact factor: 3.352

4. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors: R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal: Am J Vet Res Date: 1970-03 Impact factor: 1.156

5. A herpesvirus isolated from kidney cell culture of normal turkeys.

Authors: H Kawamura; D J King; D P Anderson
Journal: Avian Dis Date: 1969-11 Impact factor: 1.577

6. Protection against Marek's disease by vaccination with a herpesvirus of turkeys.

Authors: W Okazaki; H G Purchase; B R Burmester
Journal: Avian Dis Date: 1970-05 Impact factor: 1.577

7. Studies on the etiology of Marek's disease. II. Finding of a herpesvirus in cell culture.

Authors: K Nazerian; J J Solomon; R L Witter; B R Burmester
Journal: Proc Soc Exp Biol Med Date: 1968-01

8. An ICP6::lacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesis.

Authors: D J Goldstein; S K Weller
Journal: J Virol Date: 1988-08 Impact factor: 5.103

9. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.

Authors: P C Weber; M Levine; J C Glorioso
Journal: Science Date: 1987-05-01 Impact factor: 47.728

10. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.

Authors: R L Witter; J M Sharma; L F Lee; H M Opitz; C W Henry
Journal: Avian Dis Date: 1984 Jan-Mar Impact factor: 1.577

16 in total

1. Sequence determination and genetic content of an 8.9-kb restriction fragment in the short unique region and the internal inverted repeat of Marek's disease virus type 1 DNA.

Authors: M Sakaguchi; T Urakawa; Y Hirayama; N Miki; M Yamamoto; K Hirai
Journal: Virus Genes Date: 1992-11 Impact factor: 2.332

2. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors: K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal: J Virol Date: 2000-04 Impact factor: 5.103

3. Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors: M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal: J Virol Date: 1999-02 Impact factor: 5.103

4. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.

Authors: K Tsukamoto; S Saito; S Saeki; T Sato; N Tanimura; T Isobe; M Mase; T Imada; N Yuasa; S Yamaguchi
Journal: J Virol Date: 2002-06 Impact factor: 5.103

5. The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus.

Authors: A S Anderson; M S Parcells; R W Morgan
Journal: J Virol Date: 1998-03 Impact factor: 5.103

6. Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene.

Authors: M S Parcells; A S Anderson; R W Morgan
Journal: Virus Genes Date: 1994-09 Impact factor: 2.332

7. Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames.

Authors: M S Parcells; A S Anderson; J L Cantello; R W Morgan
Journal: J Virol Date: 1994-12 Impact factor: 5.103

8. Nucleotide sequence analysis of an infectious laryngotracheitis virus gene corresponding to the US3 of HSV-1 and a unique gene encoding a 67 kDa protein.

Authors: K Kongsuwan; C T Prideaux; M A Johnson; M Sheppard; S Rhodes
Journal: Arch Virol Date: 1995 Impact factor: 2.574

9. Expression of a novel Marek's disease virus type 1 (MDV1)-specific protein p40 in insect cells by a baculovirus vector and in chick embryo fibroblasts infected with MDV1.

Authors: T Urakawa; M Sakaguchi; M Yamamoto; G S Zhu; K Hirai
Journal: Arch Virol Date: 1994 Impact factor: 2.574

10. Alterations in DNA sequence and RNA transcription of the Bam HI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus.

Authors: N Ross; M M Binns; M Sanderson; K A Schat
Journal: Virus Genes Date: 1993-02 Impact factor: 2.332